DCGO Stock Recent News
DCGO LATEST HEADLINES
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, announced today that management will be participating in the following investor conferences in August and September: Midwest Ideas Conference (August 28th – 29th) Norm Rosenberg, Chief Financial Officer will participate in 1x1 meetings, and deliver a presentation on Wednesday August 28th at 3:45PM. A webcast of the event will be available on the investor relations sec.
DocGo Inc. (DCGO) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.07 per share. This compares to loss of $0.02 per share a year ago.
DocGo Inc. (NASDAQ:DCGO ) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Mike Cole – Vice President, Investor Relations Lee Bienstock - Chief Executive Officer Norman Rosenberg - Chief Financial Officer Conference Call Participants Sarah James - Cantor Fitzgerald Mike Latimore - Northland Capital Markets David Larsen – BTIG Pito Chickering - Deutsche Bank David Grossman - Stifel Ryan MacDonald - Needam Richard Close - Canaccord Genuity Operator Good day everyone, and welcome to the DocGo Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that Exceptional Medical Transportation, a DocGo subsidiary with a specialty in Critical Care Transportation, has been awarded a one-year, $4 million contract extension to provide 911 basic life support services to the City of Atlantic City. The contract, which started on August 1, 2024, includes two additional one-year renewal options.
LOS ANGELES, CA / ACCESSWIRE / July 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / July 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / July 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / July 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / July 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / July 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.